Market-Moving News for October 3rd
Market-Moving News for October 3rd
LEVI: -12% | Levi Strauss & Co shares are trading lower after the company reported worse-than-expected Q3 sales results and issued its FY24 adjusted EPS guidance with its midpoint below estimates. The company began a strategic review for its Dockers brand and is exploring a potential sale or other strategic transactions.
LEVI：-12% | Levis Strauss & Co的股票下跌，因为公司报告了低于预期的Q3销售成绩，并发布了FY24调整后的每股收益指引，中间点低于预期。公司已开始就其Dockers品牌展开战略审查，并正在探索潜在的出售或其他战略交易。
TOVX: 61% | Theriva Biologics Announces Outcome Of Data And Safety Monitoring Committee Review In Phase 1b/2a Clinical Trial Of SYN-004 In Allogeneic Hematopoietic Cell Transplant Recipients; The DSMC Has Recommended That The Study Proceed To Enroll Cohort 3
TOVX：61% | Theriva 生物制品宣布阿洛基因造血干细胞移植受试者中SYN-004的1b/2a临床试验数据和安全监测委员会审查结果; DSMC建议研究继续招募第3队。
NVDA: 2% | Nvidia CEO Jensen Huang Says Demand For Next-Gen Blackwell GPU Platform Insane: 'Everyone Wants To Have The Most, And Everyone Wants To Be First'
NVDA：2% | 英伟达CEO黄仁勋表示，对下一代Blackwell gpu芯片-云计算平台的需求疯狂：'每个人都想拥有最多，每个人都想第一'
